Israel Englander Illumina, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Illumina, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 25,800 shares of ILMN stock, worth $3.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,800

Previous 1,485,599 98.26%

Holding current value

$3.73 Million

Previous $155 Million 97.83%

% of portfolio

0.0%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$105.28 - $135.9 $2.26 Million - $2.91 Million	-21,448 Reduced 1.44%	1,464,151 $191 Million
Q2 2024 Aug 14, 2024	BUY	$101.05 - $133.57 $115 Million - $152 Million	1,140,247 Added 330.17%	1,485,599 $155 Million
Q1 2024 May 15, 2024	BUY	$127.73 - $147.2 $23.2 Million - $26.8 Million	181,919 Added 111.31%	345,352 $47.4 Million
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $15.2 Million - $23.3 Million	163,433 New	163,433 $22.8 Million
Q1 2023 May 15, 2023	BUY	$193.75 - $232.55 $4.69 Million - $5.62 Million	24,185 Added 832.53%	27,090 $6.3 Million
Q4 2022 Feb 14, 2023	SELL	$187.24 - $242.74 $90.7 Million - $118 Million	-484,152 Reduced 99.4%	2,905 $587,000
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $73.8 Million - $94.7 Million	416,354 Added 588.88%	487,057 $92.9 Million
Q2 2022 Aug 15, 2022	SELL	$181.58 - $368.0 $23.8 Million - $48.1 Million	-130,812 Reduced 64.91%	70,703 $13 Million
Q1 2022 May 16, 2022	BUY	$303.87 - $423.8 $4.48 Million - $6.24 Million	14,732 Added 7.89%	201,515 $70.4 Million
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $30.1 Million - $36.5 Million	-86,593 Reduced 31.68%	186,783 $71.1 Million
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $87.7 Million - $114 Million	216,294 Added 378.92%	273,376 $111 Million
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $45.6 Million - $58.9 Million	-122,387 Reduced 68.19%	57,082 $27 Million
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $52.1 Million - $72.7 Million	144,119 Added 407.69%	179,469 $68.9 Million
Q4 2020 Feb 16, 2021	BUY	$292.7 - $370.96 $2.77 Million - $3.51 Million	9,468 Added 36.58%	35,350 $13.1 Million
Q3 2020 Nov 16, 2020	BUY	$268.51 - $400.74 $4.24 Million - $6.32 Million	15,782 Added 156.26%	25,882 $8 Million
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $1.14 Million - $1.66 Million	-4,452 Reduced 30.59%	10,100 $3.74 Million
Q4 2019 Feb 14, 2020	SELL	$288.29 - $335.49 $126,559 - $147,280	-439 Reduced 2.93%	14,552 $4.83 Million
Q3 2019 Nov 14, 2019	SELL	$266.84 - $378.23 $13 Million - $18.4 Million	-48,699 Reduced 76.46%	14,991 $4.56 Million
Q2 2019 Aug 15, 2019	SELL	$300.59 - $368.15 $52.4 Million - $64.1 Million	-174,249 Reduced 73.23%	63,690 $23.4 Million
Q2 2019 Aug 14, 2019	BUY	$300.59 - $368.15 $49.6 Million - $60.8 Million	165,046 Added 226.42%	237,939 $29.3 Million
Q1 2019 May 14, 2019	SELL	$272.57 - $321.18 $50.6 Million - $59.6 Million	-185,478 Reduced 71.79%	72,893 $22.6 Million
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $7.12 Million - $9.58 Million	-26,130 Reduced 9.18%	258,371 $77.5 Million
Q3 2018 Nov 14, 2018	SELL	$279.04 - $367.06 $73.8 Million - $97.1 Million	-264,456 Reduced 48.17%	284,501 $104 Million
Q2 2018 Aug 14, 2018	BUY	$228.17 - $292.07 $86.1 Million - $110 Million	377,283 Added 219.77%	548,957 $153 Million
Q1 2018 May 15, 2018	BUY	$209.54 - $253.91 $34.2 Million - $41.5 Million	163,300 Added 1950.08%	171,674 $40.6 Million
Q4 2017 Feb 14, 2018	SELL	$202.23 - $230.03 $35.7 Million - $40.6 Million	-176,528 Reduced 95.47%	8,374 $1.83 Million
Q3 2017 Nov 14, 2017	BUY	$172.3 - $213.93 $31.9 Million - $39.6 Million	184,902	184,902 $36.8 Million

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account